Is extended 11-core biopsy valuable in benign prostatic hyperplasia patients with intermediate serum prostate-specific antigen (4.1–10 ng/ml) and prior negative sextant biopsy?

References

• Epstein JI, Walsh PC, Sauvageot J, Carter BB. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol 1997; 158: 1886–90.
   PubMed Web of Science ®Google Scholar
• Norberg M, Egevad L, Holmberg L, Sparen P. Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50: 562–4.
   PubMed Web of Science ®Google Scholar
• Naughton CK, Smith DS, Humphrey PA, Catalona WJ, Keetch DW. Clinical and pathological tumour charac-teristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. Urology 1998; 52: 808–13.
   Google Scholar
• Presti JC Jr, Chang JJ, Bhargava V. Shinohara K. The optimal systematic prostate biopsy scheme should included 8 rather than 6 biopsies. Results of a prospective clinical trial. J Urol 2000; 163: 163–7.
   Google Scholar
• Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71–5.
   PubMed Web of Science ®Google Scholar
• Ellis WJ, Brawer MK. Repeat needle biopsy: who needs it? J Urol 1995; 153: 1496–8.
   PubMed Web of Science ®Google Scholar
• Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000; 163: 152–7.
   PubMed Web of Science ®Google Scholar
• Durkan GC, Shiekh N, Johnson P, Hildreth AJ, Greene DR. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int 2002; 89: 33–9.
   Google Scholar
• Ravery V. Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000; 164: 393–6.
   Google Scholar
• Ravery V. Billebaud T, Toublanc M, Boccon Gibod L, Hermieu if, Moulinier F, et al. Diagnostic value of ten systemic TRUS-guided prostate biopsies. Eur Urol 1999; 35: 298–303.
   PubMed Web of Science ®Google Scholar
• Klaus FG, Lumper W, Hutarew G, Sollererder-Belcl R, Jungwirth A, Nikolaus S. A single 10 core prostate bi-opsy is superior to two sets of sextant prostate biopsy. Eur Urol 2000; 37 (Suppl 2): 293A.
   Google Scholar
• Eskew LA, Bare RE. McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199–202.
   Google Scholar
• Beurton D, Izadifar V. Bathelemy Y, Desgrippes A, Fontaine E. 12 systematic prostate biopsies are superior to sextant biopsies for diagnosing carcinoma: a prospective randomized study. Eur Urol 2000; 37 (Suppl 2): 296A.
   Google Scholar
• Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WD. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000; 164: 388–92.
   Google Scholar
• Nava L, Montorsi F, Consonni P, Scattoni V, Guazzoni G, Rigatti P. Results of a prospective randomized study comparing 6, 12 and 18 transrectal, ultrasound guided, sextant biopsies in patients with elevated PSA, normal DRE and normal prostatic ultra-sound. J Urol 1997; 157 (Suppl): 59 (abstract 226).
   Google Scholar
• Presti JC Jr, O'Dowd GJ, Miller MC, Matti]. R, Veltri RW. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 2003; 169: 125–9.
   PubMed Web of Science ®Google Scholar
• Fleshner N, Klotz L. Role of saturation biopsy in the detection of prostate cancer among difficult diagnostic cases. Urology 2002; 60: 93–7.
   PubMed Web of Science ®Google Scholar
• Borboroglu RG, Comer SW, Riffenburgh RH, Amling CL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000; 163: 158–62.
   PubMed Web of Science ®Google Scholar
• Karakiewicz PI, Bazinet M, Aprikian AG, Trudel C, Aronson S, Nachabe M, et al. Outcome of sextant biopsy according to gland volume. Urology 1997; 49: 55–9.
   PubMed Web of Science ®Google Scholar
• ling JO, San Francisco IF, Regan MM, DeWolf WC, Olumi AF. The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection. J Urol 2003; 169: 130–5.
   PubMedGoogle Scholar
• Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ. Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997; 158: 2168–75.
   Google Scholar
• Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000; 89: 1800–9.
   Google Scholar
• Ishizuka O, Iijima K, Ishikawa M, Hirakata S, Nagai T, Ueki T, et al. Importance of transition zone biopsies in patients undergoing ultrasound-guided prostate system-atic biopsies for the first time. Urol Int 2002; 69: 102–5.
   PubMed Web of Science ®Google Scholar
• Kojima Y, Nonomura N, Nose T, Inoue T, Tsuda K, Narumi Y, et al. Transition zone biopsy in the detection of prostate cancer. Eur Urol 2000; 37: 675–9.
   PubMed Web of Science ®Google Scholar
• Liu IJ, Macy M, Lai YH, Terris MK. Critical evaluation of the current indications for transition zone biopsy. Urology 2001; 57: 1117–20.
   PubMed Web of Science ®Google Scholar
• San Francisco IF, DeWolf WC, Rosen S, Upton M, Olumi AF. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol 2003; 169: 136–40.
   Google Scholar